a month ago
NBIX
AnalystsAndrew S. FeinAndrew S. Fein's Stock Forecasts
AnalystsAndrew S. Fein
Analyst Ranking
Top 10%
#510 out of 5213 analysts
Average Return
+24.99%
Win Rate
62%32 out of 52
Risk vs Reward
Poor
Good
Andrew S. Fein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Day One Biopharmaceuticals IncDAWN | +266.90% | $5.80 | $21.28 | 2025-08-05 - 2026-03-10 | Buy |
Palvella Therapeutics IncPVLA | +200.44% | $47.30 | $142.11 | 2025-08-14 - 2026-03-10 | Buy |
Palvella Therapeutics IncPVLA | +146.33% | $57.69 | $142.11 | 2025-09-24 - 2026-03-10 | Buy |
Arvinas IncARVN | +121.63% | $6.24 | $13.83 | 2025-08-06 - 2026-03-10 | Buy |
Savara IncSVRA | +84.54% | $3.04 | $5.61 | 2025-08-14 - 2026-03-10 | Buy |
Andrew S. Fein Analyst Color
Get additional color on Andrew S. Fein's coverage of popular stocks
3 months ago
BCRX
Andrew S. Fein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vertex Pharmaceuticals IncVRTX | 4 | Buy | $641.00 | +28.41% | Maintains | a day ago |
Liquidia CorpLQDA | 3 | Buy | $55.00 | +41.64% | Maintains | 5 days ago |
Amylyx Pharmaceuticals IncAMLX | 2 | Buy | $34.00 | +126.97% | Maintains | 7 days ago |
Wave Life Sciences LtdWVE | 3 | Buy | $30.00 | +118.18% | Reiterates | 9 days ago |
United Therapeutics CorpUTHR | 2 | Buy | $600.00 | +11.98% | Maintains | 13 days ago |
Palvella Therapeutics IncPVLA | 5 | Buy | $255.00 | +79.44% | Maintains | 15 days ago |
Insmed IncINSM | 3 | Buy | $230.00 | +59.89% | Reiterates | 16 days ago |
Neurocrine Biosciences IncNBIX | 2 | Buy | $192.00 | +47.85% | Maintains | a month ago |
Biogen IncBIIB | 1 | Buy | $228.00 | +21.01% | Maintains | a month ago |
Metavia IncMTVA | 2 | Buy | $40.00 | +2,480.65% | Maintains | 2 months ago |
Savara IncSVRA | 3 | Buy | $10.00 | +78.25% | Maintains | 3 months ago |
Dbv Technologies SaDBVT | 3 | Buy | $40.00 | +69.92% | Maintains | 3 months ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Buy | $32.00 | +265.71% | Maintains | 3 months ago |
Kymera Therapeutics IncKYMR | 3 | Buy | $134.00 | +58.43% | Maintains | 3 months ago |
Kamada LtdKMDA | 1 | Buy | $13.00 | +45.09% | Maintains | 3 months ago |
Fulcrum Therapeutics IncFULC | 3 | Buy | $25.00 | +212.11% | Maintains | 3 months ago |
Madrigal Pharmaceuticals IncMDGL | 3 | Buy | $620.00 | +43.26% | Maintains | 4 months ago |
Arcturus Therapeutics Holdings IncARCT | 3 | Hold | $9.00 | +18.11% | Maintains | 4 months ago |
Prothena Corp Public Ltd CoPRTA | 3 | Buy | $30.00 | +207.06% | Maintains | 4 months ago |
Akero Therapeutics IncAKRO | 2 | Hold | $54.00 | -1.19% | Downgrades | 5 months ago |
89bio IncETNB | 2 | Hold | $14.50 | -2.29% | Downgrades | 6 months ago |
Terns Pharmaceuticals IncTERN | 1 | Hold | $7.44 | -83.57% | Assumes | 6 months ago |
Arvinas IncARVN | 1 | Buy | $18.00 | +30.15% | Maintains | 7 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Buy | $25.00 | +17.48% | Maintains | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.